MedPath

A study on the effects of Co enzyme Q 10 on improving semen quality.

Phase 4
Conditions
Male Subfertility
Registration Number
SLCTR/2014/004
Lead Sponsor
Improving Relevance and Quality of Undergraduate Education (IRQUE)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Male partners who are diagnosed to have male factor sub fertility seeking treatment at a tertiary care treatment centre
3.Age 20-45 years
4. Base line seminal fluid parameters with sperm total motility <40%, sperm concentration >15*10^6 /ml, normal morphology >4%

Exclusion Criteria

1. Any congenital or acquired anatomical defect in the genital tract.(eg. cryptorchidism, varicocele)
2. Systemic illness that is known to affect seminal fluid parameters
3. Prescription of any medication that is known affect seminal fluid parameters
4. History of chemotherapy or radiotherapy
5. Currently on any other treatment for male sub fertility
6. Known hypersensitivity for ubiquinone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of sperm motility as assessed by seminal fluid analysis (SFA) [Baseline seminal fluid analysis (SFA) at recruitment followed by monthly SFA up to 3 months]<br>
Secondary Outcome Measures
NameTimeMethod
Change of sperm concentration and sperm morphology as assessed by seminal fluid analysis (SFA) [Baseline seminal fluid analysis (SFA) at recruitment followed by monthly SFA up to 3 months]<br>
© Copyright 2025. All Rights Reserved by MedPath